What is lung cancer ? Lung cancer is cancer that forms in tissues of the lung , usually in the cells that line the air passages. It is the leading cause ...
This page contains affiliate links. If you click a link and make a purchase or sign up for a service, Online Health Directory may earn a commission at no additional cost to you. We only recommend services we believe provide genuine value. For full details, see our Affiliate Disclosure page.
What is lung cancer ? Lung cancer is cancer that forms in tissues of the lung , usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women. There are two main types: small cell lung cancer and non-small cell lung cancer . These two types grow differently and are treated differently. Non-small cell lung cancer is the more common type. Who is more likely to develop lung cancer ? Anyone can develop lung cancer , but certain factors raise your risk of getting it: Smoking. This is the most important risk factor for lung cancer . Tobacco smoking causes about 9 out of 10 cases of lung cancer in men and about 8 out of 10 cases of lung cancer in women. The more years you smoke and the more cigarettes you smoke each day, the more your risk goes up. Your risk is also greater if you smoke a lot and drink alcohol every day or take beta carotene supplements. If you have quit smoking, your risk will be lower than if you had kept smoking. But you will still have a higher risk than people who never smoked. Secondhand smoke, which is the combination of the smoke that comes from a cigarette and the smoke breathed out by a smoker. When you breathe in secondhand smoke, you are exposed to the same cancer -causing agents as smokers, although in smaller amounts. A family history of lung cancer . Being exposed to asbestos, arsenic, chromium, beryllium, nickel, soot, or tar in the workplace. Being exposed to radiation, for example from: Radiation therapy to the breast or chest Radon in the home or workplace Certain imaging tests such as CT scans HIV infection. Your risk is higher if you have HIV. However, smoking rates are higher in people who have HIV, so it's not clear whether the increased risk is from the HIV infection or from smoking. Air pollution. Studies show that living in areas with higher levels of air pollution increases your risk of lung cancer . What are the symptoms of lung cancer ? Lung cancer may not cause any signs or symptoms until the cancer is advanced. Sometimes the cancer is found during a chest x-ray done for another condition. The symptoms of lung cancer may include: Chest pain or discomfort A cough that doesn't go away or gets worse over time Coughing up blood Trouble breathing Wheezing Hoarseness Loss of appetite Weight loss for no known reason Feeling very tired Trouble swallowing Swelling in the face and/or veins in the neck How is lung cancer diagnosed? To find out if you have lung cancer , your health care provider: Will take your medical history, which includes asking about your symptoms Will ask about your family history Will do a physical exam May order certain imaging tests, such as a chest x-ray or chest CT scan May order lab tests, including tests of your blood and sputum May do a procedure to take a biopsy of the lung If you do have lung cancer , your provider will do other tests to find out if it has spread through the lungs , lymph nodes, and the rest of the body. This is called staging. Knowing the type and stage of lung cancer you have helps your provider decide what kind of treatment you need. If you have small-cell lung cancer , your provider may also do genetic testing to look for certain gene changes (variants) in your cancer cells. The results of the testing may help guide treatment. What are the treatments for lung cancer ? For most patients with lung cancer , current treatments do not cure the cancer . Your treatment will depend on which type of lung cancer you have, how far it has spread, your overall health, and other factors. You may get more than one type of treatment. The treatments for small cell lung cancer may include: Surgery. Chemotherapy. Radiation therapy. Immunotherapy. Laser therapy, which uses a laser beam to kill cancer cells. Endoscopic stent placement. An endoscope is a thin, tube-like instrument used to look at tissues inside the body. It may be used to put in a device called a stent. The stent helps to open an airway that has been blocked by abnormal tissue. The treatments for non-small cell lung cancer may include: Surgery. Radiation therapy. Chemotherapy. Targeted therapy, which uses drugs or other substances that attack specific cancer cells with less harm to normal cells. Immunotherapy. Laser therapy. Photodynamic therapy (PDT), which uses a medicine and a certain type of laser light to kill cancer cells. Cryosurgery, which uses an instrument to freeze and destroy abnormal tissue. Electrocautery, a treatment that uses a probe or needle heated by an electric current to destroy abnormal tissue. Can lung cancer be prevented? Avoiding the risk factors may help prevent lung cancer . For example, you can: Quit smoking. And if you don't smoke, don't start. Lower your exposure to hazardous substances at work. Lower your exposure to radon. Radon tests can show whether your home has high levels of radon. You can buy a test kit yourself or hire a professional to do the test. NIH: National Cancer Institute Health topic information sourced from MedlinePlus, a service of the National Library of Medicine, National Institutes of Health.
Health topic information on this page is sourced from MedlinePlus, a service of the National Library of Medicine, National Institutes of Health. Visit medlineplus.gov for more information.
FDA-approved medications commonly prescribed for lung cancer. This is not medical advice — a clinician decides which treatment fits your situation.
1 INDICATIONS AND USAGE MEKINIST is a kinase inhibitor indicated as a single agent for the treatment of BRAF-inhibitor treatment-naïve patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test. ( 1.1 , 2.1 ) MEKINIST is indicated, in combination with dabrafenib, for: the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test. ( 1.1 , 2.1 ) the adjuvant…
5 WARNINGS AND PRECAUTIONS New Primary Malignancies, Cutaneous and Non-Cutaneous : Can occur when MEKINIST is used with dabrafenib. Monitor patients for new malignancies prior to, or while on therapy, and following discontinuation of treatment. ( 5.1 ) Hemorrhage : Major hemorrhagic events can…
Manufacturer: Novartis Pharmaceuticals Corporation
1 INDICATIONS AND USAGE LORBRENA ® is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test. LORBRENA is a kinase inhibitor indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test. ( 1 , 2.1 )
5 WARNINGS AND PRECAUTIONS • Risk of Serious Hepatotoxicity with Concomitant Use of Strong CYP3A Inducers : Discontinue strong CYP3A inducers for 3 plasma half-lives of the strong CYP3A inducer prior to initiating LORBRENA. ( 2.4 , 5.1 ) • Central Nervous System (CNS) Effects : CNS effects include…
Manufacturer: U.S. Pharmaceuticals
Recruiting trials that involve lung cancer. Trial status changes often — always confirm with the trial coordinator before traveling.
No recruiting clinical trials are listed for this condition right now. Search ClinicalTrials.gov directly for the most current list.
A oncologist is typically the right starting point for lung cancer.
Browse oncologists by city →No spam. Unsubscribe any time.
By subscribing you agree to our Privacy Policy. We will never share your data with third parties.
Skip the waiting room and connect with a licensed US doctor for lung cancer questions and prescriptions where appropriate.
This page provides general health information for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
1 INDICATIONS AND USAGE Docetaxel Injection is a microtubule inhibitor indicated for: • Breast Cancer (BC): single agent for locally advanced or metastatic BC after chemotherapy failure; and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node-positive BC ( 1.1 ) • Non-small Cell Lung Cancer (NSCLC): single agent for locally advanced or metastatic NSCLC after platinum therapy failure; and with cisplatin for unresectable, locally advanced or metastatic untreated NSCLC (…
BLACK BOX WARNING: WARNING: TOXIC DEATHS, HEPATOTOXICITY, NEUTROPENIA, HYPERSENSITIVITY REACTIONS, and FLUID RETENTION Treatment-related mortality associated with docetaxel is increased in patients with abnormal liver function, in patients receiving higher doses, and in patients with non-small…
Manufacturer: Hospira, Inc.
1 INDICATIONS AND USAGE Pemetrexed for Injection is a folate analog metabolic inhibitor indicated: in combination with pembrolizumab and platinum chemotherapy, for the initial treatment of patients with metastatic non-squamous non-small cell lung cancer (NSCLC), with no EGFR or ALK genomic tumor aberrations. ( 1.1 ) in combination with cisplatin for the initial treatment of patients with locally advanced or metastatic, non-squamous NSCLC. ( 1.1 ) as a single agent for the maintenance treatment…
5 WARNINGS AND PRECAUTIONS Myelosuppression: Can cause severe bone marrow suppression resulting in cytopenia and an increased risk of infection. Do not administer pemetrexed for injection when the absolute neutrophil count is less than 1500 cells/mm 3 and platelets are less than 100,000 cells/mm 3…
1 INDICATIONS AND USAGE Gemcitabine Injection is a nucleoside metabolic inhibitor indicated: • in combination with carboplatin, for the treatment of advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy. ( 1.1 ) • in combination with paclitaxel, for first-line treatment of metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, unless anthracyclines were clinically contraindicated. ( 1.2 ) • in combination…
5 WARNINGS AND PRECAUTIONS • Schedule-Dependent Toxicity: Increased toxicity with infusion time greater than 60 minutes or dosing more frequently than once weekly. ( 5.1 ) • Myelosuppression: Monitor for myelosuppression prior to each cycle and reduce or withhold dose for severe myelosuppression.…
Manufacturer: Mylan Institutional LLC